Serostatus May Modify RA Activity–CV Link - Scorecard - MDSpire

Serostatus May Modify RA Activity–CV Link

Combined rheumatoid factor and anticitrullinated protein antibody status appeared to modify the association between baseline rheumatoid arthritis disease activity and subsequent cardiovascular events in an international observational cohort.

  • By

  • Andrea Surnit

  • July 15, 2026

  • 4 min

Share

Clinical Scorecard: Serostatus May Modify RA Activity–CV Link

At a Glance

CategoryDetail
ConditionRheumatoid Arthritis
Key MechanismsAssociation between rheumatoid arthritis disease activity and major adverse cardiovascular events, modified by serostatus.
Target PopulationPatients with prevalent rheumatoid arthritis and no established or suspected cardiovascular disease.
Care SettingAcademic referral centers

Key Highlights

  • Higher rheumatoid arthritis disease activity linked to increased risk of cardiovascular events.
  • Each 1-unit increase in DAS28-CRP associated with an 18% higher hazard of cardiovascular events.
  • Combined serostatus of RF and ACPA may influence cardiovascular risk assessment.
  • 184 patients experienced a first major adverse cardiovascular event during follow-up.
  • Caution advised against interpreting low disease activity as low cardiovascular risk.

Guideline-Based Recommendations

Diagnosis

  • Assess disease activity using DAS28-CRP.

Management

  • Consider serostatus when evaluating cardiovascular risk in rheumatoid arthritis patients.

Monitoring & Follow-up

  • Monitor disease activity and cardiovascular risk factors at enrollment.

Risks

  • Patients with low disease activity should not be assumed to have low cardiovascular risk.

Patient & Prescribing Data

Patients with rheumatoid arthritis enrolled in the ATACC-RA consortium.

Corticosteroid use and traditional cardiovascular risk factors should be considered in management.

Clinical Best Practices

  • Evaluate combined serostatus for cardiovascular risk assessment.
  • Use imaging-based risk reclassification in selected serologic groups.

Related Resources & Content

Original Source(s)

Serostatus May Modify RA Activity–CV Link

  • by Andrea Surnit

  • July 15, 2026

Related Content

Healthcare utilization and costs in patients with rheumatoid arthritis using biologics or tofacitinib: a nationwide, population-based study

Obesity Not Associated With Worse Long-Term TAR Outcomes

A long-term cohort study found that obesity was not associated with worse patient-reported outcomes or higher reoperation rates following total ankle replacement in optimized surgical candidates.

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.